Companies · Software / Tech

BioSig Technologies, Inc.

LOS ANGELES · Software / Tech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on BioSig Technologies, Inc. — recommendation, valuation, rhythm, risks.
$65.7M
Total raised · real
39
Rounds
0.3×
Latest step-up
Top 8%
Sector rank · raised
Recurring offerings
Latest stage · inferred · Wed Mar 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

BioSig Technologies, Inc. has raised $66M over 39 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Active
  • Last raise 16 mo ago; this sector typically re-raises about every 13 months.
  • Raising on or ahead of the sector's normal rhythm.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Recurring offering issuermedium confidence

BioSig Technologies, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Program-like
Frequent filings and follow-ons read more like a securities offering program than discrete startup rounds.
Lifecycle
14.8 yr record
Peak capital year was 2023 with $22.5M across 14 filings.
Market position
ahead of 93% of Software / Tech peers
Capital scale is ahead of 93% of Software / Tech peers; modeled value is above 12% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Lower applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • 52 dated financing filings, averaging about 3 months apart.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2023: $22.5M across 14 filings.
  • Largest single filing was $8.6M on 2019-03-14.
  • Filing rows sum to $85.2M, while canonical raised total is $65.7M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Software / Tech

BioSig Technologies, Inc. is one of 3920 Software / Tech companies tracked from LOS ANGELES. By capital raised it ranks among the largest (ahead of 93% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
11
Investors (latest)
2025-03-05
First sale
Amount raised vs valuation, by year

This issuer has a dense recurring filing history, so the chart groups filings by year. Solid bars are annual reported capital reported; hatched bars show the latest modeled value est. observed in that year. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Annual capital raised · realLatest value in year · estCumulative funded · real

Dense history compressed: 52 filings shown as 14 yearly buckets. Hover a bucket for filing count, annual capital, and latest modeled value.

$0$50M$100M$150M$200M2011: 3 filings Raised $2.7M total (real) Latest modeled valuation $38M (est)20113 filings2013: 6 filings Raised $11M total (real) Latest modeled valuation $22M (est)20136 filings2014: 9 filings Raised $14M total (real) Latest modeled valuation $111M (est)20149 filings2015: 2 filings Raised $1.5M total (real) Latest modeled valuation $28M (est)20152 filings2016: 1 filing Raised $520K total (real) Latest modeled valuation $14M (est)20161 filings2017: 2 filings Raised $3.6M total (real) Latest modeled valuation $55M (est)20172 filings2018: 2 filings Raised $5.6M total (real) Latest modeled valuation $113M (est)20182 filings2019: 4 filings Raised $13M total (real) Latest modeled valuation $19M (est)20194 filings2020: 1 filing Raised $600K total (real) Latest modeled valuation $17M (est)20201 filings2021: 1 filing Raised $600K total (real) Latest modeled valuation $11M (est)20211 filings2022: 3 filings Raised $4.0M total (real) Latest modeled valuation $11M (est)20223 filings2023: 14 filings Raised $23M total (real) Latest modeled valuation $6.3M (est)202314 filings2024: 3 filings Raised $5.6M total (real) Latest modeled valuation $17M (est)20243 filings2025: 1 filing Raised $819K total (real) Latest modeled valuation $3.4M (est)20251 filingsCumulative $85M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps

This looks like a recurring offering series, so a VC stage ladder would be misleading. Showing the filed offering sequence instead.

Initial offering$922K · 2011
Follow-on offering$922K · 2011
Follow-on offering$888K · 2011
Follow-on offering$2.2M · 2013
Follow-on offering$2.4M · 2013
Follow-on offering$1.8M · 2013
Follow-on offering$2.8M · 2013
Follow-on offering$792K · 2013
Follow-on offering$528K · 2013
Follow-on offering$574K · 2014
Follow-on offering$205K · 2014
Follow-on offering$563K · 2014
Follow-on offering$953K · 2014
Follow-on offering$1.6M · 2014
Follow-on offering$2.4M · 2014
Follow-on offering$512K · 2014
Follow-on offering$3.0M · 2014
Follow-on offering$4.0M · 2014
Follow-on offering$450K · 2015
Follow-on offering$1.0M · 2015
Follow-on offering$520K · 2016
Follow-on offering$1.6M · 2017
Follow-on offering$2.0M · 2017
Follow-on offering$1.5M · 2018

Showing first 24 of 52 filings to keep the sequence readable.

Modeled valuation trajectory
$3.4M
Base estimate est.
$1.1M
Conservative case
$6.3M
Upside case
$3.7M
Modeled post-money

This issuer files recurring offerings, so the model treats stage labels as a loose sizing heuristic, not a clean VC ladder. The estimate anchors on reported filing amounts and dates, then applies benchmark dilution, survival, and markup assumptions. Directional, not a quoted figure.

Pre-Seed · modeled $39.1M · 2011-09-192011Pre-Seed · modeled $39.1M · 2011-09-19Pre-Seed · modeled $37.6M · 2011-12-27Seed · modeled $76.2M · 2013-02-12Seed · modeled $82.5M · 2013-02-12Seed · modeled $62.0M · 2013-02-12Seed · modeled $94.8M · 2013-02-12Seed · modeled $27.0M · 2013-12-31Pre-Seed · modeled $22.4M · 2013-12-31Seed · modeled $19.6M · 2014-04-04Pre-Seed · modeled $8.7M · 2014-04-04Pre-Seed · modeled $23.9M · 2014-08-15Seed · modeled $32.5M · 2014-08-15Seed · modeled $53.9M · 2014-12-19Seed · modeled $82.6M · 2014-12-19Pre-Seed · modeled $21.7M · 2014-12-19Seed · modeled $101.6M · 2014-12-19Series A · modeled $111.2M · 2014-12-19Series A · modeled $12.5M · 2015-05-11Series A · modeled $28.3M · 2015-10-23Series A · modeled $14.4M · 2016-10-28Series A · modeled $45.5M · 2017-04-06Series A · modeled $55.5M · 2017-11-03Series A · modeled $41.6M · 2018-02-16Series A · modeled $112.9M · 2018-08-13Series A · modeled $239.1M · 2019-03-14Series A · modeled $90.4M · 2019-08-05Series A · modeled $4.4M · 2019-09-05Series A · modeled $19.0M · 2019-10-21Series A · modeled $16.6M · 2020-02-25Series A · modeled $11.0M · 2021-07-07Series A · modeled $15.4M · 2022-11-18Seed · modeled $15.9M · 2022-11-18Series A · modeled $11.2M · 2022-12-21Seed · modeled $18.6M · 2023-01-10Series A · modeled $18.1M · 2023-01-10Series A · modeled $18.7M · 2023-01-23Series A · modeled $2.3M · 2023-01-25Series A · modeled $19.4M · 2023-02-03Series A · modeled $5.8M · 2023-02-08Series A · modeled $23.6M · 2023-03-14Series A · modeled $13.8M · 2023-03-24Series A · modeled $12.5M · 2023-04-18Series A · modeled $32.1M · 2023-05-16Series A · modeled $17.6M · 2023-07-31Series A · modeled $6.0M · 2023-09-12Series A · modeled $8.8M · 2023-09-21Series A · modeled $6.3M · 2023-10-12Series A · modeled $9.8M · 2024-01-12Series A · modeled $6.7M · 2024-05-01Series A · modeled $17.1M · 2024-05-29Series A · modeled $3.4M · 2025-03-052025
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
54%
Survival probability
29% low · 74% high
1.50×/yr
Annual markup
1.89×/yr upside case
1.3 yr
Elapsed time used
1.3 yr actual, capped for stale marks
technology
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
3 mo
Avg between rounds
$4.9M/yr
Capital velocity
14.8 yr
On record since
2011
First round
52
Rounds on file
How it compares to the market

Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 14× above median
This company$65.7M
Sector median$4.6M
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$3.4M
Sector median$36.6M

Raised more than 93% of sector peers (real $). Modeled value above 12% of peers (estimate).

Full financing history

This issuer files too frequently for VC stage labels to be meaningful, so rows are shown as initial/follow-on offerings est. instead of Pre-Seed/Seed/Series buckets.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Initial offering$922K2011-09-19$5.1M$39.1M85%
Follow-on offering$922K2011-09-19$5.1M$39.1M85%
Follow-on offering$888K2011-12-27$4.9M$37.6M85%
Follow-on offering$2.2M2013-02-12$11.2M$76.2M85%
Follow-on offering$2.4M2013-02-12$12.1M$82.5M85%
Follow-on offering$1.8M2013-02-12$9.1M$62.0M85%
Follow-on offering$2.8M2013-02-12$13.9M$94.8M85%
Follow-on offering$792K2013-12-31$4.0M$27.0M85%
Follow-on offering$528K2013-12-31$2.9M$22.4M85%
Follow-on offering$574K2014-04-04$2.9M$19.6M85%
Follow-on offering$205K2014-04-04$1.1M$8.7M85%
Follow-on offering$563K2014-08-15$3.1M$23.9M85%
Follow-on offering$953K2014-08-15$4.8M$32.5M85%
Follow-on offering$1.6M2014-12-19$7.9M$53.9M85%
Follow-on offering$2.4M2014-12-19$12.1M$82.6M85%
Follow-on offering$512K2014-12-19$2.8M$21.7M85%
Follow-on offering$3.0M2014-12-19$14.9M$101.6M85%
Follow-on offering$4.0M2014-12-19$18.2M$111.2M85%
Follow-on offering$450K2015-05-11$2.0M$12.5M85%
Follow-on offering$1.0M2015-10-23$4.6M$28.3M85%
Follow-on offering$520K2016-10-28$2.4M$14.4M90%
Follow-on offering$1.6M2017-04-06$7.5M$45.5M90%
Follow-on offering$2.0M2017-11-03$9.1M$55.5M90%
Follow-on offering$1.5M2018-02-16$6.8M$41.6M90%
Follow-on offering$4.1M2018-08-13$18.5M$112.9M90%
Follow-on offering$8.6M2019-03-14$39.2M$239.1M90%
Follow-on offering$3.3M2019-08-05$14.8M$90.4M90%
Follow-on offering$160K2019-09-05$727K$4.4M90%
Follow-on offering$686K2019-10-21$3.1M$19.0M90%
Follow-on offering$600K2020-02-25$2.7M$16.6M90%
Follow-on offering$600K2021-07-07$2.7M$11.0M90%
Follow-on offering$1.5M2022-11-18$6.6M$15.4M90%
Follow-on offering$1.5M2022-11-18$7.3M$15.9M90%
Follow-on offering$1.1M2022-12-21$5.0M$11.2M90%
Follow-on offering$1.8M2023-01-10$9.1M$18.6M90%
Follow-on offering$1.8M2023-01-10$8.2M$18.1M90%
Follow-on offering$1.9M2023-01-23$8.6M$18.7M90%
Follow-on offering$234K2023-01-25$1.1M$2.3M90%
Follow-on offering$2.0M2023-02-03$9.1M$19.4M90%
Follow-on offering$603K2023-02-08$2.7M$5.8M90%
Follow-on offering$2.5M2023-03-14$11.5M$23.6M90%
Follow-on offering$1.5M2023-03-24$6.8M$13.8M90%
Follow-on offering$1.4M2023-04-18$6.3M$12.5M90%
Follow-on offering$3.7M2023-05-16$16.8M$32.1M90%
Follow-on offering$2.2M2023-07-31$10.0M$17.6M90%
Follow-on offering$794K2023-09-12$3.6M$6.0M90%
Follow-on offering$1.2M2023-09-21$5.3M$8.8M90%
Follow-on offering$861K2023-10-12$3.9M$6.3M90%
Follow-on offering$1.5M2024-01-12$6.7M$9.8M90%
Follow-on offering$1.1M2024-05-01$5.2M$6.7M90%
Follow-on offering$3.0M2024-05-29$13.6M$17.1M90%
Follow-on offering$819K2025-03-05$3.7M$3.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Initial offering$922K2011-09-19
    • First recorded raise — entered as Initial offering.
    • 20 investors on this round.
  2. Follow-on offering$922K2011-09-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 20 investors on this round.
  3. Follow-on offering$888K2011-12-27
    • Came back fast: 3 mo vs the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 24 investors on this round.
  4. Follow-on offering$2.2M2013-02-12
    • Raised 14 mo later, in step with the ~13 mo sector norm.
    • Round 2.5× larger than the prior — scaling up.
    • 24 investors on this round.
  5. Follow-on offering$2.4M2013-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 28 investors on this round.
  6. Follow-on offering$1.8M2013-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 16 investors on this round.
  7. Follow-on offering$2.8M2013-02-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • 41 investors on this round.
  8. Follow-on offering$792K2013-12-31
    • Raised 11 mo later, in step with the ~13 mo sector norm.
    • Round 3.5× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 16 investors on this round.
  9. Follow-on offering$528K2013-12-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  10. Follow-on offering$574K2014-04-04
    • Came back fast: 3 mo vs the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 28 investors on this round.
  11. Follow-on offering$205K2014-04-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.8× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  12. Follow-on offering$563K2014-08-15
    • Came back fast: 4 mo vs the ~13 mo sector norm.
    • Round 2.7× larger than the prior — scaling up.
    • 13 investors on this round.
  13. Follow-on offering$953K2014-08-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× larger than the prior — scaling up.
    • 23 investors on this round.
  14. Follow-on offering$1.6M2014-12-19
    • Came back fast: 4 mo vs the ~13 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • 40 investors on this round.
  15. Follow-on offering$2.4M2014-12-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • 62 investors on this round.
  16. Follow-on offering$512K2014-12-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.7× smaller than the prior — bridge or down round.
    • 24 investors on this round.
  17. Follow-on offering$3.0M2014-12-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 5.8× larger than the prior — scaling up.
    • 75 investors on this round.
  18. Follow-on offering$4.0M2014-12-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× larger than the prior — scaling up.
    • 107 investors on this round.
  19. Follow-on offering$450K2015-05-11
    • Came back fast: 5 mo vs the ~13 mo sector norm.
    • Round 8.9× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  20. Follow-on offering$1.0M2015-10-23
    • Came back fast: 5 mo vs the ~13 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
    • 14 investors on this round.
  21. Follow-on offering$520K2016-10-28
    • Raised 12 mo later, in step with the ~13 mo sector norm.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  22. Follow-on offering$1.6M2017-04-06
    • Came back fast: 5 mo vs the ~13 mo sector norm.
    • Round 3.2× larger than the prior — scaling up.
    • 22 investors on this round.
  23. Follow-on offering$2.0M2017-11-03
    • Came back fast: 7 mo vs the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 2 investors on this round.
  24. Follow-on offering$1.5M2018-02-16
    • Came back fast: 3 mo vs the ~13 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  25. Follow-on offering$4.1M2018-08-13
    • Came back fast: 6 mo vs the ~13 mo sector norm.
    • Round 2.7× larger than the prior — scaling up.
    • 72 investors on this round.
  26. Follow-on offering$8.6M2019-03-14
    • Came back fast: 7 mo vs the ~13 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • 103 investors on this round.
  27. Follow-on offering$3.3M2019-08-05
    • Came back fast: 5 mo vs the ~13 mo sector norm.
    • Round 2.6× smaller than the prior — bridge or down round.
    • 17 investors on this round.
  28. Follow-on offering$160K2019-09-05
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 20.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  29. Follow-on offering$686K2019-10-21
    • Came back fast: 2 mo vs the ~13 mo sector norm.
    • Round 4.3× larger than the prior — scaling up.
    • 8 investors on this round.
  30. Follow-on offering$600K2020-02-25
    • Came back fast: 4 mo vs the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  31. Follow-on offering$600K2021-07-07
    • Raised 16 mo later, in step with the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  32. Follow-on offering$1.5M2022-11-18
    • Raised 16 mo later, in step with the ~13 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
    • 10 investors on this round.
  33. Follow-on offering$1.5M2022-11-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 10 investors on this round.
  34. Follow-on offering$1.1M2022-12-21
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  35. Follow-on offering$1.8M2023-01-10
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • 17 investors on this round.
  36. Follow-on offering$1.8M2023-01-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 17 investors on this round.
  37. Follow-on offering$1.9M2023-01-23
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  38. Follow-on offering$234K2023-01-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.1× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  39. Follow-on offering$2.0M2023-02-03
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.6× larger than the prior — scaling up.
    • 7 investors on this round.
  40. Follow-on offering$603K2023-02-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.3× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  41. Follow-on offering$2.5M2023-03-14
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 4.2× larger than the prior — scaling up.
    • 17 investors on this round.
  42. Follow-on offering$1.5M2023-03-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  43. Follow-on offering$1.4M2023-04-18
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 14 investors on this round.
  44. Follow-on offering$3.7M2023-05-16
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 2.7× larger than the prior — scaling up.
    • 20 investors on this round.
  45. Follow-on offering$2.2M2023-07-31
    • Came back fast: 2 mo vs the ~13 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  46. Follow-on offering$794K2023-09-12
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 2.8× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  47. Follow-on offering$1.2M2023-09-21
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • 10 investors on this round.
  48. Follow-on offering$861K2023-10-12
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 20 investors on this round.
  49. Follow-on offering$1.5M2024-01-12
    • Came back fast: 3 mo vs the ~13 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • 7 investors on this round.
  50. Follow-on offering$1.1M2024-05-01
    • Came back fast: 4 mo vs the ~13 mo sector norm.
    • Round roughly the size of the prior one.
    • 6 investors on this round.
  51. Follow-on offering$3.0M2024-05-29
    • Came back fast: 1 mo vs the ~13 mo sector norm.
    • Round 2.6× larger than the prior — scaling up.
    • 4 investors on this round.
  52. Follow-on offering$819K2025-03-05
    • Raised 9 mo later, in step with the ~13 mo sector norm.
    • Round 3.7× smaller than the prior — bridge or down round.
    • 11 investors on this round.
Intelligence
2025 ~Q2
Modeled next raise · ~3mo cadence
$819K
Modeled next size est.range $819K$1.3M
0.3×
Last step-up
$4.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Patrick Gallagher10 other2014-08
Jeffrey O'Donnell6 other2013-12
Jerome Zeldis5 other2015-05
Roy Tanaka5 other2013-12
Kenneth Londoner4 other2011-09
Anthony Zook3 other2021-07
Asher Holzer3 other2013-12
Patrick J. Gallagher3 other2022-11
Samuel Navarro3 other2019-08
Kalyanam Shivkumar2 other2013-12
David Weild1 other2015-10
Gregory Cash1 other2014-08
James J. Barry1 other2022-11
Steve Chaussy1 other2013-12
Andrew Filler2017-11
Anthony Amato2024-05
Asher S Holzer2013-02
Bill S Uglow2011-09
Budimir S Drakulic2011-09
Chris F. Baer2024-05
David Foley2015-10
David J Weild IV2023-02
David L. Weild IV2022-11
Donald E. Foley2022-11
Registry & provenance

BioSig Technologies, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1530766
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
NeuroClear Technologies, Inc.Software / TechSeries A$14.9M$298.2Mnetwork6 shared operators · same sector · same stage
Alliqua BioMedical, Inc.BiotechnologySeries A$52.6M$100.1Mnetwork2 shared operators · same stage
Peca Labs, Inc.Software / TechSeries A$21.2M$8.4Mnetwork1 shared operator · same sector · same stage
Algorithm Sciences, Inc.BiotechnologySeed$7.2M$1.9Mnetwork3 shared operators
NeuTrace, Inc.Other Health CareSeries A$9.8M$23.6Mnetwork2 shared operators · same stage
Ovation.io, Inc.Software / TechSeries B$31.0M$4.9Mnetwork1 shared operator · same sector
Phase Change Software LlcSoftware / TechSeries A$37.4M$4.7Msame sector · same stage
InspireMD, Inc.Other Health CareSeries C$117.2M$248.1Mnetwork2 shared operators
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
BioSig AI Sciences, Inc.AI / MLSeed$4.5M89%
DataBiologics, Inc.Other Health CarePre-Seed$11.2M83%
BC3 Technologies, Inc.Software / TechSeed$2.6M83%
SIG Medical Corp.HealthtechSeed$55.5M83%
Biosim Inc.Other TechnologySeries A$79.7M82%
Pieces Technologies, Inc.Software / TechSeries B$782.9M82%
Tissue Analytics, Inc.Software / TechSeries A$138.7M82%
BioMedx Group, Inc.Other Health CarePre-Seed$14.0M82%
Frequently asked
How much funding has BioSig Technologies, Inc. raised?
BioSig Technologies, Inc. has raised approximately $65.7M in disclosed capital across 39 recorded financing rounds, aggregated from public filings.
What is BioSig Technologies, Inc.'s estimated valuation?
Provath's modeled valuation for BioSig Technologies, Inc. is approximately $3.4M (modeled range $1.1M–$6.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is BioSig Technologies, Inc. at?
BioSig Technologies, Inc. shows a recurring offering pattern rather than a clean VC stage progression. Its most recent recorded round closed around Wed Mar 05.
What does BioSig Technologies, Inc. do and where is it based?
BioSig Technologies, Inc. operates in the Software / Tech sector, based in LOS ANGELES.
Explore related

See where BioSig Technologies, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at BioSig Technologies, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.